293 related articles for article (PubMed ID: 33948794)
1. Harm Reduction in Male Patients Actively Using Anabolic Androgenic Steroids (AAS) and Performance-Enhancing Drugs (PEDs): a Review.
Bonnecaze AK; O'Connor T; Burns CA
J Gen Intern Med; 2021 Jul; 36(7):2055-2064. PubMed ID: 33948794
[TBL] [Abstract][Full Text] [Related]
2. Common symptoms associated with usage and cessation of anabolic androgenic steroids in men.
Sharma A; Grant B; Islam H; Kapoor A; Pradeep A; Jayasena CN
Best Pract Res Clin Endocrinol Metab; 2022 Sep; 36(5):101691. PubMed ID: 35999138
[TBL] [Abstract][Full Text] [Related]
3. Gendered perspectives on women's anabolic-androgenic steroid (AAS) usage practices.
Piatkowski T; Robertson J; Lamon S; Dunn M
Harm Reduct J; 2023 Apr; 20(1):56. PubMed ID: 37098574
[TBL] [Abstract][Full Text] [Related]
4. The Availability and Acquisition of Illicit Anabolic Androgenic Steroids and Testosterone Preparations on the Internet.
McBride JA; Carson CC; Coward RM
Am J Mens Health; 2018 Sep; 12(5):1352-1357. PubMed ID: 27170675
[TBL] [Abstract][Full Text] [Related]
5. Exploring Anabolic Androgenic Steroid Use Among Cisgender Gay, Bisexual, and Queer Men.
Kutscher E; Arshed A; Greene RE; Kladney M
JAMA Netw Open; 2024 May; 7(5):e2411088. PubMed ID: 38743422
[TBL] [Abstract][Full Text] [Related]
6. The use of post-cycle therapy is associated with reduced withdrawal symptoms from anabolic-androgenic steroid use: a survey of 470 men.
Grant B; Kean J; Vali N; Campbell J; Maden L; Bijral P; Dhillo WS; McVeigh J; Quinton R; Jayasena CN
Subst Abuse Treat Prev Policy; 2023 Nov; 18(1):66. PubMed ID: 37951896
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use.
Baggish AL; Weiner RB; Kanayama G; Hudson JI; Lu MT; Hoffmann U; Pope HG
Circulation; 2017 May; 135(21):1991-2002. PubMed ID: 28533317
[TBL] [Abstract][Full Text] [Related]
8. [Interdisciplinary and Psychiatric Treatment of Anabolic Androgenic Steroids Users].
Butzke I; Iff S; Zitzmann M; Quednow BB; Claussen MC
Praxis (Bern 1994); 2022 Apr; 111(6):339-344. PubMed ID: 35473320
[TBL] [Abstract][Full Text] [Related]
9. Interdisciplinary and Psychiatric Treatment of Anabolic Androgenic Steroids Users.
Butzke I; Iff S; Zitzmann M; Quednow BB; Claussen MC
Praxis (Bern 1994); 2022 Apr; 111(6):e339-e344. PubMed ID: 35473322
[No Abstract] [Full Text] [Related]
10. Health service engagement, side effects and concerns among men with anabolic-androgenic steroid use: a cross-sectional Norwegian study.
Henriksen HCB; Havnes IA; Jørstad ML; Bjørnebekk A
Subst Abuse Treat Prev Policy; 2023 Apr; 18(1):19. PubMed ID: 37013635
[TBL] [Abstract][Full Text] [Related]
11. Severe biventricular cardiomyopathy in both current and former long-term users of anabolic-androgenic steroids.
Abdullah R; Bjørnebekk A; Hauger LE; Hullstein IR; Edvardsen T; Haugaa KH; Almaas VM
Eur J Prev Cardiol; 2024 Mar; 31(5):599-608. PubMed ID: 37992194
[TBL] [Abstract][Full Text] [Related]
12. Adverse health effects of anabolic-androgenic steroids.
van Amsterdam J; Opperhuizen A; Hartgens F
Regul Toxicol Pharmacol; 2010 Jun; 57(1):117-23. PubMed ID: 20153798
[TBL] [Abstract][Full Text] [Related]
13. Outpatient clinic for users of anabolic androgenic steroids: an overview.
Smit DL; de Ronde W
Neth J Med; 2018 May; 76(4):167. PubMed ID: 29845939
[TBL] [Abstract][Full Text] [Related]
14. A focused netnographic study exploring experiences associated with counterfeit and contaminated anabolic-androgenic steroids.
Frude E; McKay FH; Dunn M
Harm Reduct J; 2020 Jun; 17(1):42. PubMed ID: 32532347
[TBL] [Abstract][Full Text] [Related]
15. Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-Analysis.
Christou MA; Christou PA; Markozannes G; Tsatsoulis A; Mastorakos G; Tigas S
Sports Med; 2017 Sep; 47(9):1869-1883. PubMed ID: 28258581
[TBL] [Abstract][Full Text] [Related]
16. Investigating anabolic-androgenic steroid dependence and muscle dysmorphia with network analysis among male weightlifters.
Scarth M; Westlye LT; Havnes IA; Bjørnebekk A
BMC Psychiatry; 2023 May; 23(1):342. PubMed ID: 37193971
[TBL] [Abstract][Full Text] [Related]
17. Impact of anabolic androgenic steroids on male sexual and reproductive function: a systematic review.
Esposito M; Salerno M; Calvano G; Agliozzo R; Ficarra V; Sessa F; Favilla V; Cimino S; Pomara C
Panminerva Med; 2023 Mar; 65(1):43-50. PubMed ID: 35146992
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and Attitudes of Men Using Anabolic Androgenic Steroids (AAS): A Survey of 2385 Men.
Bonnecaze AK; O'Connor T; Aloi JA
Am J Mens Health; 2020; 14(6):1557988320966536. PubMed ID: 33307930
[TBL] [Abstract][Full Text] [Related]
19. Anabolic Androgenic Steroid Use Patterns and Steroid Use Disorders in a Sample of Male Gym Visitors.
de Zeeuw TI; Brunt TM; van Amsterdam J; van de Ven K; van den Brink W
Eur Addict Res; 2023; 29(2):99-108. PubMed ID: 36731448
[TBL] [Abstract][Full Text] [Related]
20. Factors predicting normalization of reproductive hormones after cessation of anabolic-androgenic steroids in men: a single center retrospective study.
Grant B; Campbell J; Pradeep A; Burns AD; Bassett P; Abbara A; Saket P; Minhas S; Dhillo WS; McVeigh J; Bhasin S; Jayasena CN
Eur J Endocrinol; 2023 Dec; 189(6):601-610. PubMed ID: 38102386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
